Learn More
Cayman Chemical MEGXhydrochlorIde 10mg

Supplier: Cayman Chemical 2801910 MG
An active metabolite of lidocaine; formed via N-deethylation of lidocaine by hepatic CYP3A4; topical administration reduces thrombus formation in a hamster model of laser-induced microvascular injury at 2% v/v; plasma levels following lidocaine administration have been used to monitor declining liver function in patients with cirrhosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.